ABLV vs MKDW
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ABLV's Piotroski F-Score of 4/9 indicates weak financial health, falling short of the stable threshold and signaling operational inefficiencies. The absence of an Altman Z-Score raises significant distress risk concerns, particularly given the company's negative ROE (-120.86%) and ROA (-11.31%), which reflect deep profitability erosion. Despite a modest price-to-book of 3.52 and a low price-to-sales of 0.30, the stock trades at a steep discount to its 52-week high, suggesting prolonged market skepticism. Revenue has declined sharply by 23.9% YoY, with no signs of recovery, and the company shows no dividend policy or analyst coverage. These factors collectively point to a high-risk, fundamentally weak entity with limited near-term upside.
MKDW exhibits severe financial distress, characterized by a mediocre Piotroski F-Score of 4/9 and a critical liquidity crisis with a current ratio of 0.30. The company suffers from negative equity (Price/Book of -10.67) and a collapsing top line, with revenue declining 61.3% year-over-year. While the stock has experienced a massive short-term price spike (+289% in one month), this is entirely decoupled from fundamentals, which show operating margins of -190.12%. The combination of negative book value and insufficient current assets suggests a high risk of insolvency.
Compare Another Pair
Related Comparisons
ABLV vs MKDW: Head-to-Head Comparison
This page compares Able View Global Inc. (ABLV) and MKDWELL Tech Inc. (MKDW) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.